Clinical Trial Update: Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating veliparib with or without carboplatin in patients with stage III or IV breast cancer has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Unresectable Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 2 | Status: COMPLETED | Results posted: 2025-08-15